trial

A Novel Treatment Approach for Self-Stigma in First Episode Psychosis

NCTId NCT03491852
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 40 (estimated)
Sponsored by Queen's University, Belfast
Primary completion 2020-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
40 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2018-04-01
Primary completion
2020-01
Eligibility
ALL · 16 Years · 65 Years

Interventions & indications

Drugs
BOOST Intervention

Sponsors

Queen's University, BelfastLead Sponsor
St. Joseph's Healthcare HamiltonCollaborator

Investigators

1
Christopher R Bowie, PhDPrincipal Investigator

Sites

1 total
Hamilton, Canada

Facts & assertions

4 sourced
Enrollment
40
Phase
NA
Primary Completion Date
2020-01
Status
UNKNOWN
relationships
The graph out of here
drug
BOOST Intervention
drug
lead_sponsor
Queen's University, Belfast
company
collaborator
St. Joseph's Healthcare Hamilton
company
indication
Psychotic Disorders
indication
Psychotic Disorders
indication
investigator
Christopher R Bowie, PhD
person